Archives

Mabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

B SHANGHAI, April 15, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company with a full industry chain, announced that the National Medical Products Administration… Login to continue reading Login…

Read MoreMabwell Announces Acceptance of Supplemental Biologics License Application by NMPA for MAIWEIJIAN (Denosumab)

Anycubic Showcases Next-Generation 3D Printing Lineup at RAPID+TCT 2026, Highlighting Multicolor FDM and Large-Format Resin Innovation

B BOSTON, April 15, 2026 /PRNewswire/ — Anycubic, a global manufacturer of desktop 3D printers and materials, presented its latest product lineup at RAPID+TCT 2026 (Booth… Login to continue reading Login…

Read MoreAnycubic Showcases Next-Generation 3D Printing Lineup at RAPID+TCT 2026, Highlighting Multicolor FDM and Large-Format Resin Innovation